INTRODUCTION: Mortality in dialysis patients is higher than in the general population, and cardiovascular disease represents the leading cause of death. Hypertension and volume overload are important risk factors for the development of left ventricular hypertrophy (LVH) in hemodialysis (HD) and peritoneal dialysis (PD) patients. Other factors are mainly represented by hyperparathyroidism, vascular calcification, arterial stiffness and inflammation. The aim of this study was to compare blood pressure (BP) and metabolic parameters with cardiovascular changes [cardiothoracic ratio (CTR), aortic arch calcification (AAC) and LV mass index (LVMI)] between PD and HD patients. MATERIALS AND METHODS: 45 patients (23 HD and 22 PD patients) were enrolled. BP measurements, echocardiography and chest X-ray were performed in each patient to determine the LVMI and to evaluate the CTR and AAC. Inflammatory indexes, intact parathyroid hormone (iPTH) and arterial blood gas analysis were also evaluated. RESULTS: LVMI was higher in PD than HD patients (139 ŷ 19 vs. 104 ŷ 22; p = 0.04). In PD patients, a significant correlation between iPTH, C-reactive protein and the presence of LVH was observed (r = 0.70, p = 0.04; r = 0.70, p = 0.03, respectively). The CTR was increased in PD patients as compared to HD patients, while no significant differences in cardiac calcifications were determined. CONCLUSIONS: Our data indicate that HD patients present more effective BP control than PD patients. Adequate fluid and metabolic control are necessary to assess the adequacy of BP, which is strongly correlated with the increase in LVMI and with the increased CTR in dialysis patients. PD is a home therapy and allows a better quality of life, but PD patients may present a further increased cardiovascular risk if not adequately monitored.
INTRODUCTION: Mortality in dialysis patients is higher than in the general population, and cardiovascular disease represents the leading cause of death. Hypertension and volume overload are important risk factors for the development of left ventricular hypertrophy (LVH) in hemodialysis (HD) and peritoneal dialysis (PD) patients. Other factors are mainly represented by hyperparathyroidism, vascular calcification, arterial stiffness and inflammation. The aim of this study was to compare blood pressure (BP) and metabolic parameters with cardiovascular changes [cardiothoracic ratio (CTR), aortic arch calcification (AAC) and LV mass index (LVMI)] between PD and HDpatients. MATERIALS AND METHODS: 45 patients (23 HD and 22 PDpatients) were enrolled. BP measurements, echocardiography and chest X-ray were performed in each patient to determine the LVMI and to evaluate the CTR and AAC. Inflammatory indexes, intact parathyroid hormone (iPTH) and arterial blood gas analysis were also evaluated. RESULTS: LVMI was higher in PD than HDpatients (139 ŷ 19 vs. 104 ŷ 22; p = 0.04). In PDpatients, a significant correlation between iPTH, C-reactive protein and the presence of LVH was observed (r = 0.70, p = 0.04; r = 0.70, p = 0.03, respectively). The CTR was increased in PDpatients as compared to HDpatients, while no significant differences in cardiac calcifications were determined. CONCLUSIONS: Our data indicate that HDpatients present more effective BP control than PDpatients. Adequate fluid and metabolic control are necessary to assess the adequacy of BP, which is strongly correlated with the increase in LVMI and with the increased CTR in dialysis patients. PD is a home therapy and allows a better quality of life, but PDpatients may present a further increased cardiovascular risk if not adequately monitored.
Entities:
Keywords:
Blood pressure; Cardiothoracic ratio; Chronic kidney disease; Inflammation; Left ventricular hypertrophy; Mineral metabolism
Authors: K Ateş; G Nergizoğlu; K Keven; A Sen; S Kutlay; S Ertürk; N Duman; O Karatan; A E Ertuğ Journal: Kidney Int Date: 2001-08 Impact factor: 10.612
Authors: N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger Journal: J Am Soc Echocardiogr Date: 1989 Sep-Oct Impact factor: 5.251
Authors: K J Jager; M P Merkus; F W Dekker; E W Boeschoten; J G Tijssen; P Stevens; W J Bos; R T Krediet Journal: Kidney Int Date: 1999-04 Impact factor: 10.612
Authors: Colin R Lenihan; Sai Liu; Medha Airy; Carl Walther; Maria E Montez-Rath; Wolfgang C Winkelmayer Journal: Cardiorenal Med Date: 2021-09-02 Impact factor: 4.360
Authors: Silvia Lai; Maria I Amabile; Matteo B Bargagli; T Gnerre Musto; Andrea Martinez; Massimo Testorio; Daniela Mastroluca; Carlo Lai; Paola Aceto; Alessio Molfino Journal: Medicine (Baltimore) Date: 2018-08 Impact factor: 1.817
Authors: Marie Hilderman; Abdul R Qureshi; Yousef Al-Abed; Farhad Abtahi; Kaj Lindecrantz; Björn Anderstam; Annette Bruchfeld Journal: Clin Kidney J Date: 2015-08-25